Metabolic response prediction using 68Ga-FAPI PET/CT in Non-Hodgkin lymphoma treated with chemotherapy: a pilot study
Abstract Background The aim of this study was to investigate the prediction value of metabolic response using gallium 68 (68Ga) labeled fibroblast-activation protein inhibitor (68Ga-FAPI) positron emission tomography-computed tomography (PET/CT) in Non-Hodgkin lymphoma (NHL) patients receiving (cycl...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2025-06-01
|
| Серія: | Cancer Imaging |
| Онлайн доступ: | https://doi.org/10.1186/s40644-025-00890-0 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|